ACADIA Pharmaceuticals Inc.
ACAD
$29.70
$0.311.06%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 380.48M | 375.65M | 391.00M | 261.17M | 222.16M |
| Total Depreciation and Amortization | 12.02M | 11.80M | 11.76M | 14.05M | 13.67M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -184.42M | -198.28M | -203.17M | -104.74M | -93.40M |
| Change in Net Operating Assets | -47.77M | -65.68M | -89.76M | 28.46M | 45.47M |
| Cash from Operations | 160.32M | 123.49M | 109.84M | 198.95M | 187.91M |
| Capital Expenditure | -14.69M | -9.90M | -4.69M | -1.14M | -820.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 146.52M | 146.52M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -62.78M | -102.33M | -297.87M | -269.92M | -273.35M |
| Cash from Investing | -77.47M | -112.23M | -302.56M | -124.55M | -127.65M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 46.81M | 52.28M | 49.88M | 29.19M | 20.03M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 46.81M | 52.28M | 49.88M | 29.19M | 20.03M |
| Foreign Exchange rate Adjustments | 59.00K | 56.00K | 26.00K | -41.00K | -83.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 129.72M | 63.59M | -142.82M | 103.55M | 80.20M |